Regeneron

Get funding

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.

Use:
Date closing: -
Amount: -
Industry focus: Others;
Total budget: 500M $
Entity type: Venture Capital
Vertical focus: All
Website: https://www.regeneron.com/

Status:
Open
Funding type: Equity investment;
Geographic focus:
Public/Private: Private
Stage focus:
Applicant target: Startup;

Add a Review Send question

Overview

New York-based pharma Regeneron announced Monday that it is launching a $500 million venture capital fund that will invest in promising biotechnology innovation amid a renewed wave of investment activity in the biotech market.

Regeneron Pharmaceuticals will serve as the exclusive limited partner to the VC fund—called Regeneron Ventures—and commit $100 million annually over the next five years.

Founded and led by physician-scientists, their unique ability to repeatedly translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in their laboratories.

Last updated on 2024-09-12 17:40